人类癌症表现出突变型表型：起源、后果和靶向治疗。
Human cancers express mutator phenotypes: origin, consequences and targeting.
机构信息
Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98195, USA.
出版信息
Nat Rev Cancer. 2011 Jun;11(6):450-7. doi: 10.1038/nrc3063. Epub 2011 May 19.
Abstract
Recent data on DNA sequencing of human tumours have established that cancer cells contain thousands of mutations. These data support the concept that cancer cells express a mutator phenotype. This Perspective considers the evidence supporting the mutator phenotype hypothesis, the origin and consequences of a mutator phenotype, the implications for personalized medicine and the feasibility of ablating tumours by error catastrophe.
摘要
最近关于人类肿瘤 DNA 测序的研究数据表明，癌细胞中含有数千种突变。这些数据支持癌细胞表达突变表型的概念。本观点考虑了支持突变表型假说的证据、突变表型的起源和后果、对个体化医学的影响以及通过错误灾难消融肿瘤的可行性。
相似文献
1
Human cancers express mutator phenotypes: origin, consequences and targeting.
Nat Rev Cancer. 2011 Jun;11(6):450-7. doi: 10.1038/nrc3063. Epub 2011 May 19.
2
Mutator phenotype in cancer: timing and perspectives.
Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):206-13. doi: 10.1002/em.20111.
3
Cancers exhibit a mutator phenotype: clinical implications.
Cancer Res. 2008 May 15;68(10):3551-7; discussion 3557. doi: 10.1158/0008-5472.CAN-07-5835.
4
The mutator phenotype in cancer: molecular mechanisms and targeting strategies.
Curr Drug Targets. 2010 Oct;11(10):1296-303. doi: 10.2174/1389450111007011296.
5
Cancer cells exhibit a mutator phenotype.
Adv Cancer Res. 1998;72:25-56. doi: 10.1016/s0065-230x(08)60699-5.
6
Mutator phenotypes due to DNA replication infidelity.
Semin Cancer Biol. 2010 Oct;20(5):304-11. doi: 10.1016/j.semcancer.2010.10.003. Epub 2010 Oct 8.
7
A mutator phenotype in cancer.
Cancer Res. 2001 Apr 15;61(8):3230-9.
8
Human Cancers Express a Mutator Phenotype: Hypothesis, Origin, and Consequences.
Cancer Res. 2016 Apr 15;76(8):2057-9. doi: 10.1158/0008-5472.CAN-16-0794.
9
Transient expression of a mutator phenotype in cancer cells.
Science. 1997 Sep 5;277(5331):1449-50. doi: 10.1126/science.277.5331.1449.
10
Multiple mutations in human cancers.
Mutat Res. 1996 Feb 19;350(1):279-86. doi: 10.1016/0027-5107(95)00117-4.
引用本文的文献
1
A transient mutational burst occurs during yeast colony development.
Mol Syst Biol. 2025 Jun 9. doi: 10.1038/s44320-025-00117-1.
2
The Use of Mutational Signatures to Decipher the Inter-Relationship of Reactive Oxygen Species with Homologous Recombination and Non-Homologous End-Joining Deficiencies as Well as Their Effects on APOBEC Mutagenesis in Breast Cancer.
Cancers (Basel). 2025 May 12;17(10):1627. doi: 10.3390/cancers17101627.
3
Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy.
CA Cancer J Clin. 2025 May-Jun;75(3):183-202. doi: 10.3322/caac.70000. Epub 2025 Mar 9.
4
The complex interplay between aging and cancer.
Nat Aging. 2025 Mar;5(3):350-365. doi: 10.1038/s43587-025-00827-z. Epub 2025 Mar 4.
5
Tumor sequencing before and after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: Genetic tumor characterization and clinical outcome.
Clin Transl Radiat Oncol. 2024 Nov 22;50:100894. doi: 10.1016/j.ctro.2024.100894. eCollection 2025 Jan.
6
Direct and indirect selection in a proofreading polymerase.
bioRxiv. 2024 Oct 15:2024.10.14.618309. doi: 10.1101/2024.10.14.618309.
7
Multistage carcinogenesis in occupational cholangiocarcinoma: the impact of clonal expansion and risk estimation.
Genes Environ. 2024 Oct 24;46(1):21. doi: 10.1186/s41021-024-00315-7.
8
Human DNA polymerase ε is a source of C>T mutations at CpG dinucleotides.
Nat Genet. 2024 Nov;56(11):2506-2516. doi: 10.1038/s41588-024-01945-x. Epub 2024 Oct 10.
9
Evolution of evolvability in rapidly adapting populations.
Nat Ecol Evol. 2024 Nov;8(11):2085-2096. doi: 10.1038/s41559-024-02527-0. Epub 2024 Sep 11.
10
A battle between two biological singularities: Immune response vs. cancer.
Biophys Physicobiol. 2024 Feb 9;21(Supplemental):e211006. doi: 10.2142/biophysico.bppb-v21.s006. eCollection 2024.
本文引用的文献
1
8-Hydroxyguanine: From its discovery in 1983 to the present status.
Proc Jpn Acad Ser B Phys Biol Sci. 2006 May;82(4):127-41. doi: 10.2183/pjab.82.127.
2
Initial genome sequencing and analysis of multiple myeloma.
Nature. 2011 Mar 24;471(7339):467-72. doi: 10.1038/nature09837.
3
Hallmarks of cancer: the next generation.
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
4
The genomic complexity of primary human prostate cancer.
Nature. 2011 Feb 10;470(7333):214-20. doi: 10.1038/nature09744.
5
DNA polymerases and cancer.
Nat Rev Cancer. 2011 Feb;11(2):96-110. doi: 10.1038/nrc2998.
6
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Science. 2011 Mar 4;331(6021):1199-203. doi: 10.1126/science.1200609. Epub 2011 Jan 20.
7
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
Nature. 2011 Jan 27;469(7331):539-42. doi: 10.1038/nature09639. Epub 2011 Jan 19.
8
Massive genomic rearrangement acquired in a single catastrophic event during cancer development.
Cell. 2011 Jan 7;144(1):27-40. doi: 10.1016/j.cell.2010.11.055.
9
Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis.
PLoS One. 2010 Dec 22;5(12):e15661. doi: 10.1371/journal.pone.0015661.
10
The genetic landscape of the childhood cancer medulloblastoma.
Science. 2011 Jan 28;331(6016):435-9. doi: 10.1126/science.1198056. Epub 2010 Dec 16.
Zotero 插件